Enanta Pharmaceuticals (ENTA) PT Raised to $67 at RBC Capital
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $14.09 +4.29%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 32
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 32
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $67.00 (from $64.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- JPMorgan Downgrades ZTO Express (ZTO) to Overweight
- Medtronic, Inc. (MDT) PT Raised to $115 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
